16 Oct 2020
The driving factors for the virus testing diagnostic kit market are Increasing number of viral infections and virus-related diseases.
Key Players for Global Virus Testing Diagnostic Kits Market Reports–
Global Virus Testing Diagnostic Kits report covers prominent player’s Quidel Corporation, F. Hoffmann-La Roche, Alere Inc., Abbott, Thermo Fisher Scientific, Becton, Dickinson and Company, Luminex Corporation, Nectar Lifesciences, Cortez Diagnostics, and Bundi International Diagnostics and Other.
North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of seed treatment sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa and many others The regions covered in this Virus Testing Diagnostic Kits market.
Alere was a global manufacturing of rapid point-of-care diagnostic tests. The company was founded in 1991 by Ron Zwanzige. Headquartered in Waltham, Massachusetts, United States. The company had a market capitalization of $3.47 billion with an enterprise value of $5.9 billion in January 2017. The company specialists in Professional Diagnostics, Rapid Point-of-Care Testing, Cardiometabolic, Infectious Disease, and Toxicology. Abott is their parent company.
News- Abbott Laboratories agreed to purchase Alere for $5.3 billion, less than the $5.8 billion it originally agreed to pay. With uncertainties mounting on the eve of a new administration, corporate buyers look for wiggle room to get out of agreed upon deals.
Becton is an American multinational medical technology company. The company deals in manufacturing and selling medical devices, instrument systems, and reagents and also provides consulting and analytics services in certain geographies. The was founded in 1897 by Maxwell Becton and Fairleigh S. Dickinson. Headquartered in Franklin Lakes, New Jersey. Health care institutions, science researchers, clinical laboratories, the pharmaceutical industry, and the general public are the customers of the company. The company is ranked 195 in the 2019 Fortune 500 list. The company specialists in Medical Devices, Biosciences, Medical Supplies, Laboratory Instruments, Reagents, Diagnostics Products, Antibodies, Surgical, and Vascular Access. by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers the supports the heroes on the frontlines of health care. The company focuses on outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
News- Becton, Dickinson Wins Designation Allowing European Sales of Coronavirus Test. BD marks 25 years with Mercy Ships: Donates $1M to support launch of world's largest NGO hospital ship.
Bundi International Diagnostics
Bundi International Diagnostics is a company that develops, manufactures and markets high quality, low cost in vitro rapid diagnostic test kits globally. The company is founded by Rao Deva.
Abott is an American multinational medical devices and health care company. Founded in 1888; 132 years ago by Dr. Wallace Calvin Abbott with headquarters in Abbott Park, Illinois, United States. The company currently is engaged in selling medical devices, diagnostics, branded generic medicines and nutritional products. The company specialists in Nutrition, Diagnostics, Medical Devices, and Branded Generic Pharmaceuticals. Company’s 107,000 colleagues serve people in more than 160 countries. Branded generic medicines, Medical devices Diagnostic assays, Nutritionals are main products of the company.
News- Abbott launches next gen heart rhythm management devices in India. Abbott gets DCGI nod for once-a-day heart failure, angina treatment drug. Covid-19 pandemic: Abbott to supply over 1 million antibody tests to India.
Thermo Fisher Scientific is an American company. It is provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Founded by May 14, 2006; 14 years ago by merger of Thermo Electron and Fisher Scientific. Headquartered in Waltham, Massachusetts, U.S. Analytical/other equipment and instruments, laboratory reagents and consumables, science software and services—for research, discovery, analysis, and manufacturing (incl. pharmaceutical and diagnostic products) are the major products of company. The combined company has added significantly to its technologies, workforce, and revenues.
News - Thermo Fisher Scientific Launches Modular Closed Cell Processing System for Cell Therapy Manufacturing. Thermo Fisher Scientific Announces Plans to Expand Sterile Filling Capacity for Therapies and Vaccines with New Facility in Singapore.Investment supports global health and preparedness in the Asia-Pacific region.
Luminex Corporation is a biotechnology company, The company develops, manufactures and markets proprietary biological testing technologies with applications in life-sciences. In 2011, Luminex was recognized by Forbes magazine as one of the top 25 fastest growing technology companies. The company was founded in 1995 with headquarters in Austin, Texas, United States. Luminex Corporation received the Prix Galien USA award in 2011. The company specialists in Molecular Diagnostics, xMAP Technology, Life Science Research, Multiplexing, Biotechnology, and Flow Cytometry & Imaging.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2017?
- How will each segment grow over the forecast period and how much revenue will these segment account for in 2025?
- Which region has more opportunities?